세계의 저침습 수술 시장 : 제품별, 용도별, 최종 사용자별 - 예측(-2029년)

Minimally Invasive Surgery Market by Product (Robotics, Imaging, Instrument (Handheld, inflation, Guiding, electrosurgery, endoscopy)), Application (CVD, thoracic, neuro, ENT, OB/GYN, orthopedic), Enduser - Global Forecast to 2029

US $ 4,950 ￦ 7,024,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,437,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,565,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,191,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 저침습 수술(MIS) 시장 규모는 2024년 340억 달러로 추정되고, 2029년 746억 달러에 이를 전망이며, 예측기간 중 CAGR은 17.0%가 될 것으로 예측됩니다.

예측되는 저침습 수술 시장 성장의 급증은 이점의 합류에 의해 지원됩니다. 저침습 수술은 인구의 고령화, 개복 수술보다 MIS 수술의 채용률의 상승, 수술 건수 증가에 수반하는 병원수 증가가 원동력이 되고 있습니다. 게다가, 영상 및 가시화 시스템에 의한 조기 진단 및 치료의 유효성이 향상된 만성 질환 증가에 의해 저침습 수술에 의한 고도의 치료법에 대한 수요가 높아지고 있습니다. 이러한 요인은 향후 몇 년동안 저침습 수술의 채택을 형성하여 시장 내에서 견조한 확대가 촉진되고 있습니다.

조사 범위
조사 대상년도	2021-2029년
기준년	2023년
예측 기간	2024-2029년
검토 단위	금액(10억 달러)
부문	제품별, 용도별, 최종 사용자별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

저침습 수술 시장에서는 2023년부터 2029년까지 예측 기간에 심장 및 흉부 외과 부문이 최대 시장 점유율을 획득할 것으로 보입니다. 이 부문의 성장은 수술 절차, 기구 및 영상 기술의 지속적인 혁신이 심장 흉부 수술에서 저침습 접근법의 실현 가능성과 안전성을 높이기 때문입니다. 의료 종사자가 MIS 기술에 익숙해짐에 따라 복잡한 심장 흉부 수술에 이러한 방법을 채택하는 데 큰 자신감을 보여줍니다. 게다가, 비용 효율적이고 효율적인 치료 경로를 촉진하는 의료 정책과 진료 보상 체계가 진화하고 있는 것도, MIS를 심장흉부 수술의 진료에 도입하는 인센티브를 한층 더 높이고 있습니다.

최종 사용자별로 2023년에는 병원, 클리닉 및 절제 센터 부문이 세계의 저침습 수술 시장에서 가장 큰 점유율을 차지했습니다. 이 부문의 성장은 일상적인 치료에서 복잡한 개입에 이르기까지 저침습 수술의 상당 부분, 고급 MIS 기술의 채용, 임상 실천에 의한 동향 형성 등의 요인에 의해 추진되고 있습니다.

아시아태평양 시장은 건강 관리 인프라 강화를 목표로 신흥국 정부 기관의 투자 증가로 성장하고 있습니다. 기타 특전으로는 독립정형외과, 응급센터, 외상센터 증가, 환자 고령화, 아시아태평양에서 MIS 제품 제공을 확대하는 업계 진출기업의 전략적 이니셔티브 등이 있습니다.

본 보고서에서는 세계의 저침습 수술 시장에 대해 조사했으며, 제품별, 용도별, 최종 사용자별, 지역별 동향 및 시장 진출기업 프로파일 등을 정리했습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 시장 역학
• Porter's Five Forces 분석
• 관세 및 규제 상황
• 주요 규제 지침
• 생태계 분석
• 기술 분석
• 밸류체인 분석
• 공급망 분석
• 주요 이해관계자 및 구매 기준
• 환급 시나리오
• 가격 분석
• 특허 분석
• 무역 분석
• 사례 연구
• 주된 회의 및 이벤트(2023-2024년)
• 고객의 비즈니스에 영향을 미치는 동향 및 혼란
• 저침습 수술 시장 : 경기 후퇴의 영향
• 저침습 수술 시장에서 충족되지 않은 고객 요구
• 투자 시나리오

제6장 저침습 수술 시장 : 제품별

• 서문
• 외과용 기기
• 이미징 및 시각화 시스템
• 전기 수술용 장비
• 내시경 장치
• 의료용 로봇

제7장 저침습 수술 시장 : 용도별

• 서문
• 심장흉부외과
• 혈관 수술
• 신경외과
• 이비인후과 및 호흡기 외과
• 미용 성형
• 소화기 및 복부 수술
• 부인과 수술
• 비뇨기과 수술
• 정형외과
• 종양외과
• 치과 수술
• 기타

제8장 저침습 수술 시장 : 최종 사용자별

• 서문
• 병원, 클리닉 및 어블레이션 센터
• 외래수술센터(ASC)
• 정형외과, 구급 및 외상 센터
• 기타

제9장 저침습 수술 시장 : 지역별

• 서문
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제10장 경쟁 구도

• 개요
• 주요 진입기업의 전략 및 비책
• 수익분배 분석
• 시장 점유율 분석
• 기업 평가 매트릭스(주요 진출기업)
• 기업평가 매트릭스 : 스타트업 및 중소기업
• 경쟁 시나리오
• 기업가치평가 및 재무지표
• 제품 및 브랜드 비교

제11장 기업 프로파일

• 주요 진출기업
  • MEDTRONIC PLC
  • JOHNSON & JOHNSON MEDTECH
  • STRYKER CORPORATION
  • BOSTON SCIENTIFIC CORPORATION
  • ABBOTT LABORATORIES
  • ZIMMER BIOMET HOLDINGS, INC.
  • B. BRAUN MELSUNGEN AG
  • NUVASIVE, INC.
  • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • ATEC SPINE
  • SIEMENS HEALTHINEERS AG
  • COOK MEDICAL
  • FUJIFILM CORPORATION
  • BECTON, DICKINSON AND COMPANY
  • PHILIPS HEALTHCARE
  • GLOBUS MEDICAL, INC.
• 기타 기업
  • INTUITIVE SURGICAL INC.
  • KARL STORZ
  • EDWARDS LIFESCIENCES CORPORATION
  • SMITH NEPHEW
  • GE HEALTHCARE
  • GETINGE AB
  • CONMED CORPORATION
  • TELEFLEX INCORPORATED
  • ACCURAY
  • OLYMPUS CORPORATION
  • MASIMO
  • COOPERSURGICAL INC.
  • APPLIED MEDICAL
  • RICHARD WOLF

제12장 부록

AJY

영문 목차

영문목차

The global minimally invasive surgery market is projected to reach USD 74.6 billion by 2029 from USD 34.0 billion in 2024, growing at a CAGR of 17.0% during the forecast period. The projected surge in market growth for minimally invasive surgery is underpinned by a confluence of advantages. Minimally invasive surgery are driven by an aging population, rising adoption of MIS over open surgeries, and an increasing numbers of hospitals with the increase in the number of surgical procedures. Furthermore, the increasing incidences of chronic disorders with improved efficacy for early diagnosis through imaging and visualization systems and treatment amplifies the demand for advanced modalities, with minimally invasive surgery. These factors are poised to create the phase of robust expansion within the market, consequently shaping the minimally invasive surgerry adoption in the coming forecasting years.

Scope of the Report
Years Considered for the Study	2021-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD) Billion
Segments	Product, Application, End User and Region
Regions covered	North America, Europe, Asia Pacific, Latin America and Middle East & Africa

"Cardio-thoracic surgery segment to register largest market share in 2023-2029."

Based on the application, the minimally invasive surgery market is segmented into cardiothoracic, vascular urology, neurological surgeries, ENT & Respiratory surgery, Cosmetic surgery, Gastrointestinal & Abdominal surgery, Gynecological surgery, Orthopedic, Oncology, Dental and other surgery. The cardio-thoracic surgery segment registered the largest market share over the forecast period of 2023-2029. The growth of this segment is due to the continuous innovation in surgical techniques, instruments, and imaging technology enhances the feasibility and safety of minimally invasive approaches in cardio-thoracic surgery. As medical practitioners gain proficiency in MIS techniques, they demonstrate greater confidence in employing these methods for complex cardio-thoracic procedures. Moreover, evolving healthcare policies and reimbursement structures that promote cost-effective and efficient treatment pathways further incentivize the integration of MIS into cardio-thoracic surgery practices.

"Hospitals, Clinics & Ablation centers segment held the largest share of minimally invasive surgery market in 2023, by End-user."

Based on the end-user, the minimally invasive surgery market is segmented into Hospitals, clinics & ablations centers, Ambulatory surgical centers and orthopedic, emergency and trauma centers. In 2023, the hospitals, clinics & ablation centers segment accounted for the largest share of the global minimally invasive surgery market. The growth of this segment is being propelled by factors including a significant portion of less invasive surgeries, ranging from routine procedures to complex interventions, adoption of advanced MIS technologies, and shaping trends with their clinical practices.

"Asia Pacific to register significant growth rate in the market during the forecast period."

For the forecasting period 2024-2024, the APAC region is expected to register a significant growth rate during the forecast period. Asia Pacific comprises India, China, Japan, Australia, South Korea, and RoAPAC. The Asia-Pacific (APAC) region has witnessed a significant increase in the market growth rate for minimally invasive surgery. There are several drivers that contributed to this growth:

The Asia Pacific market is experiencing growth due to rising investments by government organisations in emerging countries aimed at enhancing healthcare infrastructure. Additionally, the market is benefiting from the rise in independent orthopedic, emergency and trauma centers, a substantial aging patient population, and strategic initiatives by industry players to expand their offerings of MIS products in the Asia Pacific region.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
• By Designation: C-level-- 27%, Director-level-18%, and Others-55%
• By Region: North America-50%, Europe-20%, Asia Pacific-15%, Latin America-10%, and the Middle East & Africa-5%

Prominent players in this market are Medtronic (Ireland), Johnson & Johnson (US), Stryker Corporation (US), Boston Scientific Corporation (US), among others.

Research Coverage

• The report studies the minimally invasive surgery market based on products, application, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro markets with respect to their growth trends, prospects, and contributions to the global minimally invasive surgery market
• The report forecasts the revenue of market segments with respect to five major regions.

Key Benefits of Buying the Report:

The report will help the new entrants/ market leaders/smaller firms in this market with investment evaluation viability within the minimally invasive surgery market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing application, end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, challenges, growth catalysts and prospects, thereby empowering strategic decision-making with astute discernment.

The report provides insights on the following pointers:

• Analysis of key drivers (increasing prevalence of chronic disorder diseases, Increasing number of hospitals coupled with increasing number of surgical procedures worldwide, adoption of MIS over open surgeries), restraints (changing regulatory landscape in medical device industry and high cost of robotic systems), opportunities (increasing adoption of advanced robotics in ASCs, Emerging markets offers high-growth opportunities), and challenges (High degree of market consolidation) influencing the growth of the minimally invasive surgery market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the minimally invasive surgery market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the minimally invasive surgery market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the minimally invasive surgery market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Medtronic (Ireland), Johnson & Johnson (US), Stryker Corporation (US), Boston Scientific Corporation (US), among others.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 REGIONS COVERED
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 MARKET STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES
  • 1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH DESIGN
  • 2.2.1 SECONDARY RESEARCH
    • 2.2.1.1 Key data from secondary sources
  • 2.2.2 PRIMARY RESEARCH
    • 2.2.2.1 Primary sources
    • 2.2.2.2 Key industry insights
    • 2.2.2.3 Breakdown of primaries
  • FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• 2.3 MARKET SIZE ESTIMATION
  • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.1.1 Approach 1: Company revenue estimation approach
  • FIGURE 4 MINIMALLY INVASIVE SURGERY MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
    • 2.3.1.2 Approach 2: Customer-based market estimation
  • FIGURE 5 MINIMALLY INVASIVE SURGERY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.3.1.3 Approach 3: Top-down approach
    • 2.3.1.4 Approach 4: Primary interviews
  • FIGURE 6 TOP-DOWN APPROACH
• 2.4 DATA TRIANGULATION AND MARKET BREAKDOWN
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
• 2.5 RESEARCH LIMITATIONS
• 2.6 STUDY ASSUMPTIONS
• 2.7 RISK ASSESSMENT
  • TABLE 1 RISK ASSESSMENT ANALYSIS
• 2.8 GROWTH RATE ASSUMPTIONS
• 2.9 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

• FIGURE 8 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
• FIGURE 9 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 10 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 11 GEOGRAPHIC SNAPSHOT OF MINIMALLY INVASIVE SURGERY MARKET

4 PREMIUM INSIGHTS

• 4.1 MINIMALLY INVASIVE SURGERY MARKET OVERVIEW
  • FIGURE 12 INCREASING ADOPTION OF MIS OVER OPEN SURGERIES TO DRIVE MARKET DURING FORECAST PERIOD
• 4.2 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 NORTH AMERICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• 4.3 MINIMALLY INVASIVE SURGERY MARKET, BY REGION AND END USER, 2023 (USD MILLION)
  • FIGURE 14 HOSPITALS, CLINICS, AND ABLATION CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
• 4.4 GEOGRAPHIC SNAPSHOT OF MINIMALLY INVASIVE SURGERY MARKET
  • FIGURE 15 FRANCE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 MARKET DYNAMICS
  • FIGURE 16 MINIMALLY INVASIVE SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.1.1 DRIVERS
    • 5.1.1.1 Increasing number of hospitals and surgeries
    • 5.1.1.2 Increasing adoption of MIS over open surgeries
    • 5.1.1.3 Advantages of robot-assisted surgery & training in rehabilitation therapy
    • 5.1.1.4 Technological advancements
  • TABLE 2 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL ROBOTS
  • 5.1.2 RESTRAINTS
    • 5.1.2.1 Changing regulatory landscape in medical devices
    • 5.1.2.2 High cost of robotic systems
  • 5.1.3 OPPORTUNITIES
    • 5.1.3.1 Emerging markets
    • 5.1.3.2 Increasing adoption of advanced robotics in ASCs
  • 5.1.4 CHALLENGES
    • 5.1.4.1 High degree of market consolidation
• 5.2 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 3 MINIMALLY INVASIVE SURGERY MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 THREAT OF SUBSTITUTES
  • 5.2.3 BARGAINING POWER OF SUPPLIERS
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 DEGREE OF COMPETITION
• 5.3 TARIFF AND REGULATORY LANDSCAPE
  • 5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.4 KEY REGULATORY GUIDELINES
  • 5.4.1 US
  • TABLE 9 US FDA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • 5.4.2 EUROPE
  • 5.4.3 JAPAN
• 5.5 ECOSYSTEM ANALYSIS
  • FIGURE 17 MINIMALLY INVASIVE SURGERY MARKET: ECOSYSTEM
  • FIGURE 18 MINIMALLY INVASIVE SURGERY MARKET: KEY PLAYERS
• 5.6 TECHNOLOGY ANALYSIS
  • 5.6.1 KEY TECHNOLOGIES
    • 5.6.1.1 Laparoscopy
    • 5.6.1.2 Ablation
    • 5.6.1.3 Electrosurgery
    • 5.6.1.4 Powered surgical products
  • 5.6.2 COMPLIMENTARY TECHNOLOGIES
    • 5.6.2.1 Robotic surgery
    • 5.6.2.2 Digital solutions (AI, IoT)
    • 5.6.2.3 Medical/Surgical imaging
  • 5.6.3 ADJACENT TECHNOLOGIES
    • 5.6.3.1 Endoscopes
    • 5.6.3.2 Surgical implants
• 5.7 VALUE CHAIN ANALYSIS
  • 5.7.1 RESEARCH & DEVELOPMENT
  • 5.7.2 PROCUREMENT & PRODUCT DEVELOPMENT
  • 5.7.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
  • FIGURE 19 MINIMALLY INVASIVE SURGERY MARKET: VALUE CHAIN ANALYSIS
• 5.8 SUPPLY CHAIN ANALYSIS
  • 5.8.1 PROMINENT COMPANIES
  • 5.8.2 SMALL & MEDIUM-SIZED COMPANIES
  • 5.8.3 END USERS
  • FIGURE 20 MINIMALLY INVASIVE SURGERY MARKET: SUPPLY CHAIN ANALYSIS
• 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
  • 5.9.2 KEY BUYING CRITERIA
• 5.10 REIMBURSEMENT SCENARIO
  • TABLE 11 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
• 5.11 PRICING ANALYSIS
  • FIGURE 21 AVERAGE SELLING PRICE OF MINIMALLY INVASIVE PRODUCTS, BY PRODUCT (FY 2021-2023)
  • FIGURE 22 AVERAGE SELLING PRICE TREND, BY REGION
• 5.12 PATENT ANALYSIS
  • FIGURE 23 PATENT DETAILS FOR MINIMALLY INVASIVE SURGERY DEVICES (JANUARY 2013-DECEMBER 2023)
• 5.13 TRADE ANALYSIS
  • TABLE 12 IMPORT DATA FOR MIS MARKET (HS CODE 9021), BY COUNTRY, 2018-2022 (USD THOUSAND)
  • TABLE 13 EXPORT DATA FOR MIS MARKET (HS CODE 3822), BY COUNTRY, 2018-2022 (USD THOUSAND)
• 5.14 CASE STUDIES
  • TABLE 14 CASE STUDY 1: ROLE OF MINIMALLY INVASIVE ROBOT-ASSISTED SURGERY IN UROLOGY
  • TABLE 15 CASE STUDY 2: PIONEERING ROBOT-ASSISTED LATERAL LUMBAR INTERBODY FUSION (LLIF) WITH EXCELSIUSGPS
• 5.15 KEY CONFERENCES AND EVENTS, 2023-2024
  • TABLE 16 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2023-2024
• 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 24 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
• 5.17 MINIMALLY INVASIVE SURGERY MARKET: RECESSION IMPACT
• 5.18 UNMET CUSTOMER NEEDS IN MINIMALLY INVASIVE SURGERY MARKET
• 5.19 INVESTMENT SCENARIO
  • FIGURE 25 NUMBER OF INVESTOR DEALS IN MINIMALLY INVASIVE SURGERY MARKET, BY KEY PLAYER, 2018-2022
  • FIGURE 26 VALUE OF INVESTOR DEALS IN MINIMALLY INVASIVE SURGERY MARKET, BY KEY PLAYER, 2018-2022 (USD MILLION)

6 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 17 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• 6.2 SURGICAL DEVICES
  • TABLE 18 SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 19 SURGICAL DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.2.1 HANDHELD INSTRUMENTS
  • TABLE 20 HANDHELD INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.1.1 Tubular retractors
      • 6.2.1.1.1 Minimized tissue trauma and better outcomes to support adoption
    • 6.2.1.2 Dilators
      • 6.2.1.2.1 Safety and efficient surgical site access to support adoption
    • 6.2.1.3 Suturing instruments
      • 6.2.1.3.1 Rising procedural volume and growing demand for MIS to drive market
    • 6.2.1.4 Probes
      • 6.2.1.4.1 Advancements in instrumentation and product launches to drive market
    • 6.2.1.5 Laser fiber devices
      • 6.2.1.5.1 Growing demand in urology, gastroenterology, and other specialties to support market growth
  • 6.2.2 GUIDING DEVICES
  • TABLE 21 GUIDING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.2.1 Guiding catheters
      • 6.2.2.1.1 Focus on functional and design improvements to drive demand
    • 6.2.2.2 Guidewires
      • 6.2.2.2.1 Rising PCTA and PTA procedural volumes to ensure demand growth
  • 6.2.3 INFLATION SYSTEMS
  • TABLE 22 INFLATION SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.3.1 Balloon catheters
      • 6.2.3.1.1 Technological advancements in balloon systems to support growth
    • 6.2.3.2 Balloon inflation systems
      • 6.2.3.2.1 Growing adoption of MIS in coronary and peripheral disease treatment to drive market
  • 6.2.4 LAPAROSCOPY DEVICES
  • TABLE 23 LAPAROSCOPY DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.4.1 Laparoscopes
      • 6.2.4.1.1 Lower risk of laparoscopic procedures to drive demand
    • 6.2.4.2 Trocars & cannulas
      • 6.2.4.2.1 Need to ensure accurate placement to support growth
    • 6.2.4.3 Graspers & dissectors
      • 6.2.4.3.1 Benefits such as increased safety and better reach to drive adoption
• 6.3 IMAGING & VISUALIZATION SYSTEMS
  • TABLE 24 IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 25 IMAGING & VISUALIZATION SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.3.1 ULTRASOUND SYSTEMS
    • 6.3.1.1 Ultrasound to hold largest share of imaging & visualization systems market
  • TABLE 26 ULTRASOUND SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.3.2 CT SCANNERS
    • 6.3.2.1 Shift toward image-guided interventions and rising disease prevalence to drive market
  • TABLE 27 CT SCANNERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.3.3 MRI SYSTEMS
    • 6.3.3.1 Wide usage and technological advancements to support growth
  • TABLE 28 MRI SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.3.4 X-RAY SYSTEMS
    • 6.3.4.1 Rising emphasis on digital X-ray systems to drive market
  • TABLE 29 X-RAY SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.3.5 VISUALIZATION SYSTEMS
    • 6.3.5.1 High levels of detail and better outcomes to drive demand
  • TABLE 30 VISUALIZATION SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
• 6.4 ELECTROSURGICAL DEVICES
  • TABLE 31 ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 32 ELECTROSURGICAL DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.4.1 ELECTROCAUTERY DEVICES
    • 6.4.1.1 Increasing plastic surgeries to drive market
  • TABLE 33 ELECTROCAUTERY DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.4.2 ELECTROSURGICAL GENERATORS & ACCESSORIES
    • 6.4.2.1 Growing use of disposables and reusable instruments to drive market
  • TABLE 34 ELECTROSURGICAL GENERATORS & ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• 6.5 ENDOSCOPY DEVICES
  • TABLE 35 ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 36 ENDOSCOPY DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.5.1 RIGID ENDOSCOPES
    • 6.5.1.1 Rigid endoscopes to hold largest market share
  • TABLE 37 RIGID ENDOSCOPES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.5.2 FLEXIBLE ENDOSCOPES
    • 6.5.2.1 Rising incidence of cancer to drive demand
  • TABLE 38 FLEXIBLE ENDOSCOPES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.5.3 DIAGNOSTIC ENDOSCOPES
    • 6.5.3.1 Role of diagnostic endoscopes to expand due to versatility and sophistication
  • TABLE 39 DIAGNOSTIC ENDOSCOPES MARKET, BY REGION, 2022-2029 (USD MILLION)
• 6.6 MEDICAL ROBOTICS
  • TABLE 40 MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 41 MEDICAL ROBOTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.6.1 ROBOTIC SYSTEMS
    • 6.6.1.1 Accuracy, efficiency, and ability to conduct highly complex procedures to support market growth
  • TABLE 42 ROB0TIC SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.6.2 ROBOTIC INSTRUMENTS
    • 6.6.2.1 Rising demand for robotic surgical procedures to drive market
  • TABLE 43 ROB0TIC INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.6.3 ROBOTIC SOFTWARE & SERVICES
    • 6.6.3.1 Need for basic training and expertise in robotic systems to drive market
  • TABLE 44 ROBOTIC SOFTWARE & SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)

7 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION

• 7.1 INTRODUCTION
  • TABLE 45 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• 7.2 CARDIOTHORACIC SURGERY
  • 7.2.1 GROWING BURDEN OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
  • TABLE 46 MINIMALLY INVASIVE SURGERY MARKET FOR CARDIOTHORACIC SURGERY, BY REGION, 2022-2029 (USD MILLION)
• 7.3 VASCULAR SURGERY
  • 7.3.1 BENEFITS SUCH AS PRECISE CUTS WITH LIMITED BLOOD LOSS IN VASCULAR SURGERY TO SUPPORT GROWTH
  • TABLE 47 MINIMALLY INVASIVE SURGERY MARKET FOR VASCULAR SURGERY, BY REGION, 2022-2029 (USD MILLION)
• 7.4 NEUROLOGICAL SURGERY
  • 7.4.1 INCREASING NUMBER OF PATIENTS SUFFERING FROM NEUROLOGICAL DISORDERS TO DRIVE SEGMENT GROWTH
  • TABLE 48 MINIMALLY INVASIVE SURGERY MARKET FOR NEUROLOGICAL SURGERY, BY REGION, 2022-2029 (USD MILLION)
• 7.5 ENT & RESPIRATORY SURGERY
  • 7.5.1 BENEFITS OF MIS IN HEAD AND NECK DISORDER TREATMENT TO DRIVE MARKET
  • TABLE 49 MINIMALLY INVASIVE SURGERY MARKET FOR ENT & RESPIRATORY SURGERY, BY REGION, 2022-2029 (USD MILLION)
• 7.6 COSMETIC SURGERY
  • 7.6.1 GROWING PREFERENCE FOR COSMETIC PROCEDURES TO DRIVE MARKET
  • TABLE 50 MINIMALLY INVASIVE SURGERY MARKET FOR COSMETIC SURGERY, BY REGION, 2022-2029 (USD MILLION)
• 7.7 GASTROINTESTINAL & ABDOMINAL SURGERY
  • 7.7.1 RISING COLORECTAL CANCER PREVALENCE TO SUPPORT DEMAND
  • TABLE 51 MINIMALLY INVASIVE SURGERY MARKET FOR GASTROINTESTINAL & ABDOMINAL SURGERY, BY REGION, 2022-2029 (USD MILLION)
• 7.8 GYNECOLOGICAL SURGERY
  • 7.8.1 GROWING NUMBER OF LAPAROSCOPIC HYSTERECTOMIES PERFORMED TO SUPPORT MARKET GROWTH
  • TABLE 52 MINIMALLY INVASIVE SURGERY MARKET FOR GYNECOLOGICAL SURGERY, BY REGION, 2022-2029 (USD MILLION)
• 7.9 UROLOGICAL SURGERY
  • 7.9.1 INCREASING PREVALENCE OF UROLOGIC CANCERS TO DRIVE ADOPTION OF MIS
  • TABLE 53 MINIMALLY INVASIVE SURGERY MARKET FOR UROLOGICAL SURGERY, BY REGION, 2022-2029 (USD MILLION)
• 7.10 ORTHOPEDIC SURGERY
  • 7.10.1 RISING GERIATRIC POPULATION AND INCREASE IN ORTHOPEDIC DISORDERS TO DRIVE MARKET
  • TABLE 54 MINIMALLY INVASIVE SURGERY MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2022-2029 (USD MILLION)
• 7.11 ONCOLOGICAL SURGERY
  • 7.11.1 GROWING DEMAND FOR RADIOTHERAPY AND CHEMOTHERAPY TO AFFECT SEGMENT GROWTH
  • TABLE 55 MINIMALLY INVASIVE SURGERY MARKET FOR ONCOLOGICAL SURGERY, BY REGION, 2022-2029 (USD MILLION)
• 7.12 DENTAL SURGERY
  • 7.12.1 EMPHASIS ON PREVENTIVE DENTAL CARE TO SUPPORT MARKET GROWTH
  • TABLE 56 MINIMALLY INVASIVE SURGERY MARKET FOR DENTAL SURGERY, BY REGION, 2022-2029 (USD MILLION)
• 7.13 OTHER SURGERIES
  • TABLE 57 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER SURGERIES, BY REGION, 2022-2029 (USD MILLION)

8 MINIMALLY INVASIVE SURGERY MARKET, BY END USER

• 8.1 INTRODUCTION
  • TABLE 58 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
• 8.2 HOSPITALS, CLINICS, AND ABLATION CENTERS
  • 8.2.1 RISING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS TO DRIVE MARKET
  • TABLE 59 MINIMALLY INVASIVE SURGERY MARKET FOR HOSPITALS, CLINICS AND ABLATION CENTERS, BY REGION, 2022-2029 (USD MILLION)
• 8.3 AMBULATORY SURGERY CENTERS
  • 8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO PROPEL GROWTH
  • TABLE 60 MINIMALLY INVASIVE SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022-2029 (USD MILLION)
• 8.4 ORTHOPEDIC, EMERGENCY, AND TRAUMA CENTERS
  • 8.4.1 RISING USE OF ROBOTIC-ASSISTED SURGICAL SYSTEMS IN ORTHOPEDICS, EMERGENCY, AND TRAUMA CARE TO SUPPORT GROWTH
  • TABLE 61 MINIMALLY INVASIVE SURGERY MARKET FOR ORTHOPEDIC, EMERGENCY, AND TRAUMA CENTERS, BY REGION, 2022-2029 (USD MILLION)
• 8.5 OTHER END USERS
  • TABLE 62 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)

9 MINIMALLY INVASIVE SURGERY MARKET, BY REGION

• 9.1 INTRODUCTION
  • TABLE 63 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2022-2029 (USD MILLION)
• 9.2 NORTH AMERICA
  • 9.2.1 NORTH AMERICA: RECESSION IMPACT
  • FIGURE 27 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT
  • TABLE 64 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 70 NORTH AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 72 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.2.2 US
    • 9.2.2.1 US to dominate North American market
  • TABLE 73 US: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 74 US: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 75 US: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 76 US: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 77 US: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 78 US: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.2.3 CANADA
    • 9.2.3.1 Rising cancer and IBD incidence to drive market
  • TABLE 79 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 80 CANADA: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 81 CANADA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 82 CANADA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 83 CANADA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 84 CANADA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• 9.3 EUROPE
  • 9.3.1 EUROPE: RECESSION IMPACT
  • TABLE 85 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 86 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 87 EUROPE: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 88 EUROPE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 89 EUROPE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 90 EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 EUROPE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 93 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.3.2 GERMANY
    • 9.3.2.1 Well-established healthcare system in Germany to boost usage of instruments
  • TABLE 94 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 95 GERMANY: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 96 GERMANY: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 97 GERMANY: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 98 GERMANY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 99 GERMANY: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.3.3 FRANCE
    • 9.3.3.1 Rising number of hip & knee surgeries to drive market
  • TABLE 100 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 101 FRANCE: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 102 FRANCE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 103 FRANCE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 104 FRANCE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 105 FRANCE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.3.4 UK
    • 9.3.4.1 High incidence of cancer in the UK to boost adoption of MIS instruments
  • TABLE 106 UK: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 107 UK: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 108 UK: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 109 UK: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 110 UK: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 111 UK: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.3.5 ITALY
    • 9.3.5.1 Demand for MIS to positively affect market growth
  • TABLE 112 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 113 ITALY: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 114 ITALY: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 115 ITALY: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 116 ITALY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 ITALY: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.3.6 SPAIN
    • 9.3.6.1 Increasing incidence of CVD to boost adoption of MIS and drive market growth
  • TABLE 118 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 119 SPAIN: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 120 SPAIN: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 121 SPAIN: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 122 SPAIN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 123 SPAIN: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.3.7 REST OF EUROPE
  • TABLE 124 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 125 REST OF EUROPE: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 REST OF EUROPE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 127 REST OF EUROPE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 128 REST OF EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 129 REST OF EUROPE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• 9.4 ASIA PACIFIC
  • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
  • FIGURE 28 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT
  • TABLE 130 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.2 JAPAN
    • 9.4.2.1 Rising geriatric population in Japan to increase prevalence of chronic conditions and support market growth
  • TABLE 139 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 140 JAPAN: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 141 JAPAN: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 142 JAPAN: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 JAPAN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 JAPAN: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.4.3 CHINA
    • 9.4.3.1 Rising disease prevalence and infrastructural improvements to support market growth
  • TABLE 145 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 146 CHINA: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 147 CHINA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 148 CHINA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 149 CHINA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 150 CHINA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.4.4 INDIA
    • 9.4.4.1 Healthcare infrastructure improvements and increasing geriatric population to drive market
  • TABLE 151 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 152 INDIA: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 153 INDIA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 INDIA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 155 INDIA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 156 INDIA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Uneven distribution of specialists to hinder market growth
  • TABLE 157 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 158 AUSTRALIA: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 AUSTRALIA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 AUSTRALIA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 161 AUSTRALIA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 162 AUSTRALIA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Growing medical tourism to favor demand for MIS
  • TABLE 163 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 164 SOUTH KOREA: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 165 SOUTH KOREA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 166 SOUTH KOREA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 SOUTH KOREA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 168 SOUTH KOREA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.4.7 REST OF ASIA PACIFIC
  • TABLE 169 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 170 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 171 REST OF ASIA PACIFIC: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 172 REST OF ASIA PACIFIC: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 173 REST OF ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 REST OF ASIA PACIFIC: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• 9.5 LATIN AMERICA
  • 9.5.1 LATIN AMERICA: RECESSION IMPACT
  • TABLE 175 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 176 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 177 LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 LATIN AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 LATIN AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 180 LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 181 LATIN AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 182 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 183 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.5.2 BRAZIL
    • 9.5.2.1 Favorable healthcare policies by government and private organizations to propel market growth
  • TABLE 184 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 185 BRAZIL: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 186 BRAZIL: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 187 BRAZIL: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 188 BRAZIL: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 189 BRAZIL: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.5.3 MEXICO
    • 9.5.3.1 Rising adoption of robotics in cosmetic surgeries to drive market
  • TABLE 190 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 191 MEXICO: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 192 MEXICO: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 193 MEXICO: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 194 MEXICO: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 195 MEXICO: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.5.4 REST OF LATIN AMERICA
  • TABLE 196 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 197 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 198 REST OF LATIN AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 199 REST OF LATIN AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 200 REST OF LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 201 REST OF LATIN AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
  • TABLE 202 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 203 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 204 MIDDLE EAST & AFRICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 205 MIDDLE EAST & AFRICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 206 MIDDLE EAST & AFRICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 207 MIDDLE EAST & AFRICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 208 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 209 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Growing demand for minimally invasive procedures

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • FIGURE 29 OVERVIEW OF STRATEGIES ADOPTED BY MINIMALLY INVASIVE SURGERY PLAYERS
• 10.3 REVENUE SHARE ANALYSIS
  • FIGURE 30 REVENUE SHARE ANALYSIS FOR KEY PLAYERS, 2018-2022 (USD MILLION)
• 10.4 MARKET SHARE ANALYSIS
  • 10.4.1 GLOBAL SURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2022
  • FIGURE 31 SURGICAL DEVICES MARKET SHARE ANALYSIS, 2022
  • 10.4.2 GLOBAL IMAGING & VISUALIZATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022
  • FIGURE 32 IMAGING & VISUALIZATION SYSTEMS MARKET SHARE ANALYSIS, 2022
  • 10.4.3 GLOBAL ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2022
  • FIGURE 33 ENDOSCOPY DEVICES MARKET SHARE ANALYSIS, 2022
  • 10.4.4 GLOBAL ELECTROSURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2022
  • FIGURE 34 ELECTROSURGICAL DEVICES MARKET SHARE ANALYSIS, 2022
  • 10.4.5 GLOBAL MEDICAL ROBOTICS MARKET SHARE, BY KEY PLAYER, 2022
  • FIGURE 35 MEDICAL ROBOTICS MARKET SHARE ANALYSIS, 2022
  • FIGURE 36 MINIMALLY INVASIVE SURGERY MARKET SHARE, BY PLAYER (2023)
  • TABLE 210 MINIMALLY INVASIVE SURGERY MARKET: DEGREE OF COMPETITION
• 10.5 COMPANY EVALUATION MATRIX (KEY PLAYERS)
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • FIGURE 37 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
  • 10.5.5 COMPANY FOOTPRINT
  • FIGURE 38 COMPANY FOOTPRINT (15 COMPANIES)
  • TABLE 211 PRODUCT FOOTPRINT (15 COMPANIES)
  • TABLE 212 REGIONAL FOOTPRINT (15 COMPANIES)
  • TABLE 213 APPLICATION FOOTPRINT (15 COMPANIES)

• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 STARTING BLOCKS
  • 10.6.3 RESPONSIVE COMPANIES
  • 10.6.4 DYNAMIC COMPANIES
  • FIGURE 39 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022
  • 10.6.5 COMPANY BENCHMARKING
  • TABLE 214 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 215 MINIMALLY INVASIVE SURGERY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
• 10.7 COMPETITIVE SCENARIO
  • 10.7.1 PRODUCT LAUNCHES & APPROVALS
  • TABLE 216 MINIMALLY INVASIVE SURGERY MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2021-OCTOBER 2023)
  • 10.7.2 DEALS
  • TABLE 217 MINIMALLY INVASIVE SURGERY MARKET: DEALS (JANUARY 2021-OCTOBER 2023)
• 10.8 COMPANY VALUATION AND FINANCIAL METRICS
  • FIGURE 40 EV/EBITDA OF KEY VENDORS
  • FIGURE 41 5-YEAR STOCK BETA OF KEY VENDORS
• 10.9 PRODUCT/BRAND COMPARISON
  • FIGURE 42 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL (2023)

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
• (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
• 11.1.1 MEDTRONIC PLC
• TABLE 218 MEDTRONIC PLC: COMPANY OVERVIEW
• FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
• TABLE 219 MEDTRONIC PLC: PRODUCTS OFFERED
• TABLE 220 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• TABLE 221 MEDTRONIC PLC: DEALS (JANUARY 2020-DECEMBER 2023)
• 11.1.2 JOHNSON & JOHNSON MEDTECH
• TABLE 222 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW
• FIGURE 44 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2022)
• TABLE 223 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED
• TABLE 224 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• TABLE 225 JOHNSON & JOHNSON: DEALS (JANUARY 2020-DECEMBER 2023)
• 11.1.3 STRYKER CORPORATION
• TABLE 226 STRYKER CORPORATION: COMPANY OVERVIEW
• FIGURE 45 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
• TABLE 227 STRYKER CORPORATION: PRODUCTS OFFERED
• TABLE 228 STRYKER CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• TABLE 229 STRYKER CORPORATION: DEALS (JANUARY 2020-DECEMBER 2023)
• 11.1.4 BOSTON SCIENTIFIC CORPORATION
• TABLE 230 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
• FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
• TABLE 231 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
• TABLE 232 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• TABLE 233 BOSTON SCIENTIFIC CORPORATION: DEALS (JANUARY 2020-DECEMBER 2023)
• 11.1.5 ABBOTT LABORATORIES
• TABLE 234 ABBOTT LABORATORIES: COMPANY OVERVIEW
• FIGURE 47 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
• TABLE 235 ABBOTT LABORATORIES: PRODUCTS OFFERED
• TABLE 236 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• 11.1.6 ZIMMER BIOMET HOLDINGS, INC.
• TABLE 237 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW
• FIGURE 48 ZIMMER BIOMET HOLDINGS: COMPANY SNAPSHOT (2022)
• TABLE 238 ZIMMER BIOMET HOLDINGS: PRODUCTS OFFERED
• TABLE 239 ZIMMER BIOMET HOLDINGS: PRODUCT APPROVALS (JANUARY 2020-DECEMBER 2023)
• 11.1.7 B. BRAUN MELSUNGEN AG
• TABLE 240 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
• FIGURE 49 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
• TABLE 241 B. BRAUN MELSUNGEN: PRODUCTS OFFERED
• 11.1.8 NUVASIVE, INC.
• TABLE 242 NUVASIVE, INC: COMPANY OVERVIEW
• FIGURE 50 NUVASIVE, INC: COMPANY SNAPSHOT (2022)
• TABLE 243 NUVASIVE INC.: PRODUCTS OFFERED
• TABLE 244 NUVASIVE, INC: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• TABLE 245 NUVASIVE INC.: DEALS (JANUARY 2020-DECEMBER 2023)
• 11.1.9 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
• TABLE 246 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY OVERVIEW
• FIGURE 51 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
• TABLE 247 INTEGRA LIFESCIENCES HOLDING CORPORATION: PRODUCTS OFFERED
• 11.1.10 ATEC SPINE
• TABLE 248 ATEC SPINE: COMPANY OVERVIEW
• FIGURE 52 ATEC SPINE: COMPANY SNAPSHOT (2022)
• TABLE 249 ATEC SPINE: PRODUCTS OFFERED
• 11.1.11 SIEMENS HEALTHINEERS AG
• TABLE 250 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
• FIGURE 53 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
• TABLE 251 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
• TABLE 252 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (JANUARY 2020-DECEMBER 2023)
• TABLE 253 SIEMENS HEALTHINEERS AG: DEALS (JANUARY 2020-DECEMBER 2023)
• TABLE 254 SIEMENS HEALTHINEERS AG: EXPANSIONS (JANUARY 2020-DECEMBER 2023)
• 11.1.12 COOK MEDICAL
• TABLE 255 COOK MEDICAL: COMPANY OVERVIEW
• TABLE 256 COOK MEDICAL: PRODUCTS OFFERED
• 11.1.13 FUJIFILM CORPORATION
• TABLE 257 FUJIFILM CORPORATION: COMPANY OVERVIEW
• FIGURE 54 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022)
• TABLE 258 FUJIFILM CORPORATION: PRODUCTS OFFERED
• TABLE 259 FUJIFILM CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• TABLE 260 FUJIFILM CORPORATION: DEALS (JANUARY 2020-DECEMBER 2023)
• TABLE 261 FUJIFILM CORPORATION: EXPANSION (JANUARY 2020-DECEMBER 2023)
• TABLE 262 FUJIFILM CORPORATION: OTHER DEVELOPMENTS (JANUARY 2020-DECEMBER 2023)
• 11.1.14 BECTON, DICKINSON AND COMPANY
• TABLE 263 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
• FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
• TABLE 264 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
• TABLE 265 BECTON, DICKINSON AND COMPANY: DEALS (JANUARY 2020-DECEMBER 2023)
• TABLE 266 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS (JANUARY 2020-DECEMBER 2023)
• 11.1.15 PHILIPS HEALTHCARE
• TABLE 267 PHILIPS HEALTHCARE: COMPANY OVERVIEW
• FIGURE 56 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022)
• TABLE 268 PHILIPS HEALTHCARE: PRODUCTS OFFERED
• TABLE 269 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• TABLE 270 PHILIPS HEALTHCARE: DEALS (JANUARY 2020-DECEMBER 2023)
• 11.1.16 GLOBUS MEDICAL, INC.
• TABLE 271 GLOBUS MEDICAL, INC.: COMPANY OVERVIEW
• FIGURE 57 GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT (2022)
• TABLE 272 GLOBUS MEDICAL: PRODUCTS OFFERED
• TABLE 273 GLOBUS MEDICAL: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
• 11.2 OTHER PLAYERS
  • 11.2.1 INTUITIVE SURGICAL INC.
  • TABLE 274 INTUITIVE SURGICAL INC.: COMPANY OVERVIEW
  • FIGURE 58 INTUITIVE SURGICAL INC.: COMPANY SNAPSHOT (2022)
  • TABLE 275 INTUITIVE SURGICAL INC.: PRODUCTS OFFERED
  • TABLE 276 INTUITIVE SURGICAL, INC.: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
  • TABLE 277 INTUITIVE SURGICAL, INC.: DEALS (JANUARY 2020-DECEMBER 2023)
  • 11.2.2 KARL STORZ
  • TABLE 278 KARL STORZ: COMPANY OVERVIEW (2022)
  • TABLE 279 KARL STORZ: PRODUCTS OFFERED
  • TABLE 280 KARL STORZ: DEALS (JANUARY 2020-DECEMBER 2023)
  • TABLE 281 KARL STORZ: EXPANSIONS (JANUARY 2020-DECEMBER 2023)
  • 11.2.3 EDWARDS LIFESCIENCES CORPORATION
  • TABLE 282 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
  • FIGURE 59 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
  • TABLE 283 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
  • 11.2.4 SMITH+NEPHEW
  • TABLE 284 SMITH+NEPHEW: COMPANY OVERVIEW
  • FIGURE 60 SMITH+NEPHEW: COMPANY SNAPSHOT (2022)
  • TABLE 285 SMITH+NEPHEW: PRODUCTS OFFERED
  • TABLE 286 SMITH+NEPHEW: PRODUCT LAUNCHES (JANUARY 2020-DECEMBER 2023)
  • TABLE 287 SMITH+ NEPHEW: DEALS (JANUARY 2020-DECEMBER 2023)
  • 11.2.5 GE HEALTHCARE
  • TABLE 288 GE HEALTHCARE: COMPANY OVERVIEW
  • FIGURE 61 GENERAL ELECTRIC: COMPANY SNAPSHOT (2022)
  • TABLE 289 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 290 GE HEALTHCARE: PRODUCT LAUNCHES (JANUARY 2020-DECEMBER 2023)
  • TABLE 291 GE HEALTHCARE: DEALS (JANUARY 2020-DECEMBER 2023)
  • TABLE 292 NIPRO CORPORATION: COMPANY OVERVIEW
  • FIGURE 62 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
  • TABLE 293 NIPRO CORPORATION: PRODUCTS OFFERED
  • TABLE 294 NIPRO CORPORATION: EXPANSIONS (JANUARY 2020-DECEMBER 2023)
  • 11.2.7 GETINGE AB
  • TABLE 295 GETINGE AB: COMPANY OVERVIEW
  • FIGURE 63 GETINGE AB: COMPANY SNAPSHOT (2022)
  • TABLE 296 GETINGE AB: PRODUCTS OFFERED
  • 11.2.8 CONMED CORPORATION
  • TABLE 297 CONMED CORPORATION: COMPANY OVERVIEW
  • FIGURE 64 CONMED CORPORATION: COMPANY SNAPSHOT (2022)
  • TABLE 298 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 299 CONMED CORPORATION: DEALS (JANUARY 2020-DECEMBER 2023)
  • 11.2.9 TELEFLEX INCORPORATED
  • TABLE 300 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • FIGURE 65 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
  • TABLE 301 TELEFLEX INCORPORATED: PRODUCTS OFFERED
  • TABLE 302 TELEFLEX INCORPORATION: PRODUCT LAUNCHES (JANUARY 2020-DECEMBER 2023)
  • 11.2.10 ACCURAY
  • TABLE 303 ACCURAY: COMPANY OVERVIEW
  • FIGURE 66 ACCURAY: COMPANY SNAPSHOT (2022)
  • TABLE 304 ACCURAY: PRODUCTS OFFERED
  • TABLE 305 ACCURAY: PRODUCT LAUNCHES (JANUARY 2020-DECEMBER 2023)
  • TABLE 306 ACCURAY: DEALS (JANUARY 2020-DECEMBER 2023)
  • 11.2.11 OLYMPUS CORPORATION
  • TABLE 307 OLYMPUS CORPORATION: COMPANY OVERVIEW
  • FIGURE 67 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
  • TABLE 308 OLYMPUS CORPORATION: PRODUCTS OFFERED
  • TABLE 309 OLYMPUS CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
  • TABLE 310 OLYMPUS CORPORATION: DEALS (JANUARY 2020-DECEMBER 2023)
• *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
• 11.2.12 MASIMO
• 11.2.13 COOPERSURGICAL INC.
• 11.2.14 APPLIED MEDICAL
• 11.2.15 RICHARD WOLF

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS

관련자료